Bank Negara Malaysia has cautioned that observations from other markets show that a potential sharp rise in medical claims could come from higher utilization of health services, albeit temporarily. In the short term, the average treatment cost could also increase due to poorer health conditions worsened by delays in seeking treatment. Demand-supply dynamics may also push costs higher, particularly for hospital supplies and services that may increase due to higher demand.
Due to the pandemic, many have delayed non-critical treatments or postponed medical visits to hospitals. Claims data in 2018 shows that hospital supplies and services accounted for 60% and 70% of claimable surgical and non-surgical treatment costs respectively in Malaysia.
The central bank is of the view that higher charges from pandemic-related protocols are likely to persist in the foreseeable future. However, over the longer term, how the pandemic will affect underlying medical trends remains uncertain.
It highlights that the accelerated adoption of telehealth services by international insurers during the pandemic is a notable development, and has the potential to improve efficiency and reduce the cost of healthcare. However, what remains uncertain is the effects of long Covid-19 in the insured population, which could increase the utilization of healthcare services.
While there is a possibility that the number of insurance claims could increase sharply in the near future, it is also worth noting that the number of claims had decreased year on year in 2020, with claims mostly coming from crucial treatments, the report points out.
Claim Ratio Decreases During Pandemic - As a result, the combined ratio of the medical portfolio of insurers and takaful operators had decreased. The combined ratio measures the profitability of insurers measured in percentage, whereby 100% indicates that the premiums collected have been fully depleted by claims and expenses, and there is no profit left for insurers as a return for underwriting the portfolio.
The combined ratio of life insurance and family takaful’s individual medical portfolio had hovered between 90% and 100% from 2015 to 2019.
Despite the decrease in the number of claims in 2020, the report notes that the average cost per treatment had increased by 14% for non-surgical treatments and 15% for surgical treatments. These increases far outpaced the long-term trends of 8% for non-surgical treatments per annum and 9% for surgical treatments. This was partly attributable to the more severe and urgent nature of illnesses being treated and claimed for, as well as additional costs arising from pandemic-related protocols such as lab tests for Covid-19 and higher utilization of disposable medical supplies (including personal protective equipment).
Insurance Repricing Is Inevitable - In 2020, insurance and takaful operators were supposed to reprice medical insurance premiums. However, the planned repricing exercise was deferred due to the pandemic and to preserve the affordability of medical covers.
Insurance and takaful operators will be “carefully evaluating” the risks of continuing deferrals in the repricing cycle, which is typically every three to five years, especially for portfolios with the highest combined ratios prior to the pandemic. There is considerable risk that a sharp rebound in claims once the pandemic fears subside could lead to steeper or more frequent price increases in the near term. This could have a disproportionate impact on some individual policyholders given the larger adjustment made over a shorter period of time.
Repricing is a standard feature of medical reimbursement covers to ensure the sustainability of the medical insurance or takaful portfolios. Medical insurance/takaful portfolios become unsustainable when the premiums collected are insufficient to cover the expected claims cost, expenses and profit margin of the insurance and takaful operators. It had been concerned when insurance and takaful operators delayed repricing exercises for too long as a competitive strategy.
Lengthy delays are likely to result in sharp and unexpected premium adjustments later on to catch up with claims inflation. This may leave policyholders who are unable to afford the higher premiums with limited options to obtain replacement coverage due to advancement in age or changes in their health status.
Insurance and takaful operators will be “carefully evaluating” the risks of continuing deferrals in the repricing cycle, which is typically every three to five years, especially for portfolios with the highest combined ratios prior to the pandemic. There is considerable risk that a sharp rebound in claims once the pandemic fears subside could lead to steeper or more frequent price increases in the near term. This could have a disproportionate impact on some individual policyholders given the larger adjustment made over a shorter period of time.
Repricing is a standard feature of medical reimbursement covers to ensure the sustainability of the medical insurance or takaful portfolios. Medical insurance/takaful portfolios become unsustainable when the premiums collected are insufficient to cover the expected claims cost, expenses and profit margin of the insurance and takaful operators. It had been concerned when insurance and takaful operators delayed repricing exercises for too long as a competitive strategy.
Lengthy delays are likely to result in sharp and unexpected premium adjustments later on to catch up with claims inflation. This may leave policyholders who are unable to afford the higher premiums with limited options to obtain replacement coverage due to advancement in age or changes in their health status.
No comments:
Post a Comment